Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$25.5 - $31.51 $514,666 - $635,966
20,183 Added 14.58%
158,610 $4.54 Million
Q1 2024

Apr 23, 2024

SELL
$27.7 - $35.48 $42,159 - $54,000
-1,522 Reduced 1.09%
138,427 $4.04 Million
Q4 2023

Jan 18, 2024

BUY
$26.32 - $34.31 $913,909 - $1.19 Million
34,723 Added 33.0%
139,949 $4.72 Million
Q3 2023

Oct 27, 2023

BUY
$30.68 - $40.09 $101,765 - $132,978
3,317 Added 3.25%
105,226 $3.23 Million
Q2 2023

Jul 11, 2023

BUY
$36.12 - $47.5 $800,419 - $1.05 Million
22,160 Added 27.79%
101,909 $4.08 Million
Q1 2023

Apr 17, 2023

BUY
$35.53 - $43.38 $284,311 - $347,126
8,002 Added 11.15%
79,749 $3.25 Million
Q4 2022

Jan 10, 2023

BUY
$38.19 - $57.45 $570,482 - $858,188
14,938 Added 26.3%
71,747 $0
Q3 2022

Oct 14, 2022

SELL
$51.24 - $58.89 $1.7 Million - $1.95 Million
-33,153 Reduced 36.85%
56,809 $3.02 Million
Q2 2022

Jul 11, 2022

SELL
$51.49 - $81.64 $1.63 Million - $2.58 Million
-31,579 Reduced 25.98%
89,962 $5.25 Million
Q1 2022

May 26, 2022

SELL
$60.03 - $76.49 $1.12 Million - $1.43 Million
-18,632 Reduced 13.29%
121,541 $9.28 Million
Q4 2021

Jan 12, 2022

BUY
$47.97 - $62.21 $2.72 Million - $3.53 Million
56,725 Added 67.98%
140,173 $8.43 Million
Q3 2021

Oct 18, 2021

BUY
$54.64 - $61.3 $1.18 Million - $1.33 Million
21,637 Added 35.01%
83,448 $4.67 Million
Q2 2021

Jul 12, 2021

BUY
$59.18 - $69.99 $386,682 - $457,314
6,534 Added 11.82%
61,811 $3.75 Million
Q1 2021

Apr 21, 2021

BUY
$59.31 - $78.82 $3.28 Million - $4.36 Million
55,277 New
55,277 $3.87 Million
Q1 2020

Apr 07, 2020

SELL
$28.4 - $50.7 $5,793 - $10,342
-204 Closed
0 $0
Q2 2019

Jul 16, 2019

BUY
$36.57 - $47.97 $7,460 - $9,785
204 New
204 $9,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Gradient Investments LLC Portfolio

Follow Gradient Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gradient Investments LLC with notifications on news.